Gülay Koçak

Prof. Dr. Gülay Koçak

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2012 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
GKGülay Koçak
Gülay Koçak
BHBülent Huddam
Bülent Huddam
AAAlper AZAK
Alper AZAK
LOLevent Ortabozkoyun
Levent Ortabozkoyun
MDMurat Duranay
Murat Duranay

11 September 2015 in Renal Failure
Verified
Journal Article
Open access
PDF file
MAMehmet Fatih Akdoğan
Mehmet Fatih Akdoğan
AAAlper AZAK
Alper AZAK
NDNazım Denizli
Nazım Denizli
BHBülent Huddam
Bülent Huddam
GKGülay Koçak
Gülay Koçak
MDMurat Duranay
Murat Duranay
Purpose: Patients diagnosed with chronic kidney disease (CKD) have a greater rate of cardiovascular mortality when compared with the general population. The soluble form of TNF-like weak inducer of apoptosis (TWEAK) and monocyte chemoattractan protein 1 (MCP-1) play important roles in cellular proliferation, migration and apoptosis. The current study aimed to analyze whether soluble TWEAK (sTWEAK) and MCP-1 levels are associated with the severity of coronary arterial disease (CAD) in CKD patients. Methods: Ninety-seven patients diagnosed with CKD stages 2–3 according to their estimated glomerular filtration rate and the presence of kidney injury were included in the study. Plasma sTWEAK and MCP-1 concentrations were determined using commercially available ELISA kits. Coronary angiographies were performed through femoral artery access using the Judkins technique. Results: Correlation analysis of sTWEAK and Gensini scores showed significant association (p < 0.01, r2 = 0.287). Also significant correlation has been found in MCP-1 levels and Gensini scores (p < 0.01, r2 = 0.414). When patients were divided into two groups with a limit of 17 according to their Gensini score, sTWEAK levels indicated a statistically significant difference (p < 0.01). Conclusions: Our findings support a relationship between sTWEAK and MCP-1 levels and CAD in CKD stages 2–3 patients.

26 July 2012 in Renal Failure
Verified
Journal Article
Closed access
BHBülent Huddam
Bülent Huddam
AAAlper AZAK
Alper AZAK
GKGülay Koçak
Gülay Koçak
LOLevent Ortabozkoyun
Levent Ortabozkoyun
MDMurat Duranay
Murat Duranay
Aim and background: Central venous catheter (CVC)-related blood stream infection is a major cause of morbidity and mortality in patients with end-stage renal diseases. However, CVCs are quite frequently required for vascular access in hemodialysis (HD) patients. Tunneled catheters (TCs) are widely used when a catheter is needed for a long period. However, long-term catheter survival is limited by TC-related infections. The purpose of this prospective study was to assess clinical outcomes of prophylactic antibiotics administration prior to insertion of TCs in HD patients. Material and methods: Sixty uremic patients who required TC insertion due to vascular access failure were included in our study between April 2009 and April 2010. Patients were randomized into two groups: group I and group II. Group I received 1 g of cefazolin sodium intravenously 1 h prior to catheter insertion. Group II received equal amount of saline intravenously 1 h prior to catheter insertion. The primary end points of the study were catheter loss, hospitalization, or mortality due to catheter-related infections (CRIs). The secondary end points included exit-site infection (not requiring hospitalization), tunnel infections (not requiring catheter removal), and bacteremia. Results: During the follow-up period, one patient in group I and three patients in group II reached primary end point (p < 0.05). Catheter loss due to infection was higher in group II than in group I as 6 versus 3, respectively (p < 0.05). Catheter exit-site infections, which does not require hospitalization, have been considered as secondary end points and have been detected in four patients for 7 times in group I and in six patients for 10 times in group II (p < 0.05). Tunnel infection, which does not require removal of the catheter, has been detected in two patients for 3 times in group I and in five patients for 6 times in group II (p < 0.05). Conclusion: The prophylactic antibiotic use prior to TC insertion significantly reduced CRIs, bacteremia, and catheter loss.

12 September 2012 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
BHBülent Huddam
Bülent Huddam
GKGülay Koçak
Gülay Koçak
AAAlper AZAK
Alper AZAK
MDMurat Duranay
Murat Duranay

17 January 2012 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
GKGülay Koçak
Gülay Koçak
AAAlper AZAK
Alper AZAK
HAHesna Müzeyyen Astarcı
Hesna Müzeyyen Astarcı
BHBülent Huddam
Bülent Huddam
GKGökhan Karaca
Gökhan Karaca
MDMurat Duranay
Murat Duranay

10 July 2015 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
BHBülent Huddam
Bülent Huddam
MBMurat Başaran
Murat Başaran
GKGülay Koçak
Gülay Koçak
AAAlper AZAK
Alper AZAK
FYFunda Yalçın
Funda Yalçın
MDMurat Duranay
Murat Duranay